Mary and Deryl Hart Distinguished Professor of Surgery, in the School of Medicine
Vice Chair of Research
Chief, Section of Breast Surgery
Professor of Surgery
Professor of Radiology
Education and Training
- Surgeon-in-Chief, Ucsf Helen Diller Family Cancer Center, University of California San Francisco, School of Medicine, 2009 - 2011
- Professor in Residence, Surgery, University of California San Francisco, School of Medicine, 2009 - 2011
- Chief, Division Of Breast Surgery Oncology, University of California San Francisco, School of Medicine, 2008 - 2011
- Associate Professor in Residence, Surgery, University of California San Francisco, School of Medicine, 2004 - 2009
- Assistant Professor in Residence, Surgery, University of California San Francisco, School of Medicine, 1998 - 2004
- Senior Reigstrar, General Surgical Oncology, Singapore General Hospital (Singapore), 1998 - 1999
- Fellow, Breast Surgical Oncology, Memorial Sloan-Kettering Cancer Center, 1996 - 1997
- Resident, General Surgery, Cornell University, 1992 - 1996
- Intern, General Surgery, Kaiser Foundation Hospital, 1991 - 1992
- M.P.H., University of California - Berkeley, 2006
- M.D., University of California - Los Angeles, 1991
In the News
- Duke Adds 21 Faculty to Distinguished Faculty RankMay 7, 2019
- Tar Heel of the Week: Duke cancer surgeon champions fewer mastectomiesMay 31, 2016
- The 100 Most Influential People: Surgery professor Shelley HwangApril 22, 2016
- Duke Breast Cancer Expert Named One of TIME’s 100 Most Influential People for 2016April 22, 2016
- Dr. Shelley Hwang: New measure of mastectomyMarch 22, 2016
- Double mastectomy may not be the answer for cancer in one breastMarch 18, 2016
- Quality of Life Not Notably Better for Women Choosing Double MastectomyMarch 8, 2016
- How elective breast cancer surgery affects quality of lifeMarch 8, 2016
- Biden seeks input for cancer 'moonshot' at Duke UniversityFebruary 11, 2016
- Study Aims to Resolve How To Manage Pre-Cancers of the BreastFebruary 4, 2016
- What's the Best Way to Treat Women with Stage 0 Breast Cancer?December 29, 2015
- Who can delay breast cancer treatment? A new math model adds cluesDecember 17, 2015
- With early breast cancer treatment, less may be more: StudiesDecember 10, 2015
- Why Aren't Cancer Death Rates for DCIS Falling?October 9, 2015
- Why Doctors Are Rethinking Breast Cancer TreatmentOctober 6, 2015
- Study: Chemo unnecessary in many cases of early-stage breast cancerOctober 5, 2015
- Dr. Shelley Hwang: Why doctors are rethinking breast-cancer treatmentOctober 1, 2015
- Some cancer experts see 'overdiagnosis,' question emphasis on early detectionSeptember 16, 2014
- Think pink: Lumpectomy vs. mastectomyOctober 4, 2013
Selected Grants
- Point-of-care cellular and molecular pathology of breast tumors on a cell phone
- NCI National Clinical Trials Network (UG1)
- Lumicell - PIVOTAL STUDY OF THE LUM IMAGING SYSTEM
- Using Modifiable Risk Factors to Predict Inferior Care and Survival after Breast Cancer Diagnosis: A Novel Approach to Addressing Health Disparities
- Comparison of Operative to Medical Endocrine Therapy (COMET) for Low Risk DCIS
- Breast Pre-Cancer Atlas Center
- Building Interdisciplinary Research Careers in Women's Health
- TBCRC 034: The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed with Intraductal Papilloma without Atypia or Flat Epithelial Atypia by Core Needle Biopsy
- Tissue tension, RANK and Breast Cancer Risk
- Molecular and Radiologic Predictors of Invasion in a DCIS Active Surveillance Cohort
- Genomic Diversity and the Microenvironment as Drivers of Progression in DCIS
- Translational Research in Surgical Oncology
- Characterization of Tumor Immunobiological Factors that Promote Lymphovascular Invasion and Dissemination in Locally Advanced Breast Cancer
- Regional Oncolytic Poliovirus Immunotherapy for Breast Cancer
- Preoperative Breast Radiotherapy: A Tool to Provide Individualized and Biologically-Based Radiation Therapy
- Comparing the Effectiveness of Guideline-concordant Care to Active Surveillance for DCIS: an Observational Study
- Molecular and Radiologic Predictors of Invasion in a DCIS Active Surveillance Cohort
- Targeting DAMP-induced inflammation to prevent metastasis
- Feasibility study phase C: Expansion into multiple institutions for training in the use of the LUM imaging system for intraoperative detection of residual cancer in the tumor bed of female subjects with breast cancer
- Prevent Ductal Carcinoma in Situ Invasive Overtreatment Now - PRECISION
- To estimate the mean change in MRI tumor volume from pretreatment to completion of preoperative endocrine therapy in ER(+) DCIS, as well as to determine whether 3-month change in volume correlates with 6-month change.
- Molecular and Radiologic Predictors of Invasion in a DCIS Active Surveillance Cohort
- Cancer Prevention Agent Development Program: Early Phase Clinical Research - CR
- (PQC3) Genomic Diversity and the Microenvironment as Drivers of Metastasis in DCIS
- NCI National Clinical Trials Network U10 (Year 5)
- Genetic testing for women with high-risk breast lesions
- Molecular and Radiologic Predictors of Invasion in a DCIS Active Surveillance Cohort
- Cancer Prevention Agent Development Program: Early Phase Clinical Research - FP
- The Mathematics of Breast Cancer Overtreatment: Improving Treatment Choice through Effective Communication of Personalized Cancer Risk
- Impact of the Oncotype DX DCIS Score on Treatment Decision Making in Patients with Ductal Carcinoma in Situ
- Optimizing Parameters and Techniques in Circulation Tumor Cell Collection (OPTICOLL)
- Optimizing Parameters and Techniques in Circulation Tumor Cell Collection (OPTICOLL)